EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, cilt.67, ss.1223-1229, 2011 (SCI İndekslerine Giren Dergi)
To evaluate the impact of polymorphisms in the cytochrome P450 (CYP) 2C9, 2C19 and 2C8 genes on the risk of mild hypoglycaemic attacks in patients treated with sulphonylureas.